Honglin Zhou

7.4k total citations · 3 hit papers
51 papers, 5.8k citations indexed

About

Honglin Zhou is a scholar working on Molecular Biology, Epidemiology and Cancer Research. According to data from OpenAlex, Honglin Zhou has authored 51 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 15 papers in Epidemiology and 10 papers in Cancer Research. Recurrent topics in Honglin Zhou's work include Liver Disease Diagnosis and Treatment (9 papers), Liver physiology and pathology (4 papers) and RNA Interference and Gene Delivery (4 papers). Honglin Zhou is often cited by papers focused on Liver Disease Diagnosis and Treatment (9 papers), Liver physiology and pathology (4 papers) and RNA Interference and Gene Delivery (4 papers). Honglin Zhou collaborates with scholars based in China, United States and Canada. Honglin Zhou's co-authors include Vishva M. Dixit, Randall N. Pittman, Ingrid E. Wertz, Morris J. Birnbaum, Scott A. Summers, Michael Eby, Somasekar Seshagiri, Karen O’Rourke, Rohan T. Baker and Christian Wiesmann and has published in prestigious journals such as Nature, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Honglin Zhou

48 papers receiving 5.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling

2004 1.5k citations Ingrid E. Wertz, Honglin Zhou et al. profile →
Genome-Scale RNAi Screen for Host Factors Required for HIV Replication

2008 615 citations Honglin Zhou, Min Xu et al. Cell Host & Microbe profile →
Macrophage Polarization and Its Role in Liver Disease

2021 397 citations Cheng Wang, Cheng Ma et al. Frontiers in Immunology profile →

Peers

Countries citing papers authored by Honglin Zhou

Since Specialization

Citations

This map shows the geographic impact of Honglin Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Honglin Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Honglin Zhou more than expected).

Fields of papers citing papers by Honglin Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Honglin Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Honglin Zhou. The network helps show where Honglin Zhou may publish in the future.

Co-authorship network of co-authors of Honglin Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Honglin Zhou. A scholar is included among the top collaborators of Honglin Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Honglin Zhou. Honglin Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Targeted Degradation of HCV Polymerase by GalNAc-Conjugated ApTACs for Pan-Genotypic Antiviral Therapy with High Resistance Barriers 2025 ·Journal of Medicinal Chemistry ·(unknown), Sijin Wu, Honglin Zhou, (unknown), Qingchao Li, (unknown), (unknown), Han Han, (unknown), Yan Li, Jingrui Li, Miao Chen, Min Liu, Jun Zhou, Songbo Xie	3
2	CD44‐Targeting Drug Delivery System of Exosomes Loading Forsythiaside A Combats Liver Fibrosis via Regulating NLRP3‐Mediated Pyroptosis 2023 ·Advanced Healthcare Materials ·Lihong Gong, Honglin Zhou, (unknown), Cheng Wang, Ke Fu, Cheng Ma, Yafang Zhang, Cheng Peng, (unknown)	57
3	The protective effect of forsythiaside A on 3,5-diethoxycarbonyl-1,4-dihydrocollidine-induced cholestatic liver injury in mice: Based on targeted metabolomics and molecular biology technology 2023 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Ke Fu, Shu Dai, Yanzhi Li, Cheng Ma, Xinyan Xue, Shenglin Zhang, (unknown), Honglin Zhou, Yafang Zhang, (unknown), (unknown)	5
4	Phillygenin inhibited M1 macrophage polarization and reduced hepatic stellate cell activation by inhibiting macrophage exosomal miR-125b-5p 2023 ·Biomedicine & Pharmacotherapy ·Cheng Ma, Cheng Wang, Yafang Zhang, Yanzhi Li, Ke Fu, Lihong Gong, Honglin Zhou, (unknown), (unknown)	37
5	Tetramethylpyrazine Protects Endothelial Injury and Antithrombosis via Antioxidant and Antiapoptosis in HUVECs and Zebrafish 2022 ·Oxidative Medicine and Cellular Longevity ·(unknown), Cheng Ma, Linfeng He, Li Liao, Chaocheng Guo, (unknown), Lihong Gong, Honglin Zhou, Ke Fu, (unknown), Yunxia Li	16
6	A review: Pharmacology and pharmacokinetics of Schisandrin A 2022 ·Phytotherapy Research ·Ke Fu, Honglin Zhou, Cheng Wang, Lihong Gong, Cheng Ma, Yafang Zhang, Yunxia Li	30
7	Forsythiaside A alleviated carbon tetrachloride-induced liver fibrosis by modulating gut microbiota composition to increase short-chain fatty acids and restoring bile acids metabolism disorder 2022 ·Biomedicine & Pharmacotherapy ·Ke Fu, Cheng Ma, Cheng Wang, Honglin Zhou, Lihong Gong, Yafang Zhang, Yunxia Li	40
8	Fluorescent labeling of s²T-incorporated DNA and m⁵s²U-modified RNA 2021 ·Nucleosides Nucleotides & Nucleic Acids ·Ping Yu, Honglin Zhou, Yuanyuan Li, Zhifeng Du, Rui Wang	0
9	Research progress in use of traditional Chinese medicine monomer for treatment of non-alcoholic fatty liver disease 2021 ·European Journal of Pharmacology ·Honglin Zhou, Cheng Ma, Cheng Wang, Lihong Gong, Yafang Zhang, Yunxia Li	49
10	The Potential Application of Chinese Medicine in Liver Diseases: A New Opportunity 2021 ·Frontiers in Pharmacology ·Ke Fu, Cheng Wang, Cheng Ma, Honglin Zhou, Yunxia Li	29
11	Macrophage Polarization and Its Role in Liver Disease breakdown → 2021 ·Frontiers in Immunology ·Cheng Wang, Cheng Ma, Lihong Gong, Yuqin Guo, Ke Fu, Yafang Zhang, Honglin Zhou, Yunxia Li	397
12	A review of pharmacological and pharmacokinetic properties of Forsythiaside A 2021 ·Pharmacological Research ·Lihong Gong, Cheng Wang, Honglin Zhou, Cheng Ma, Yafang Zhang, Cheng Peng, Yunxia Li	70
13	Phillygenin Attenuates Carbon Tetrachloride-Induced Liver Fibrosis via Modulating Inflammation and Gut Microbiota 2021 ·Frontiers in Pharmacology ·Cheng Wang, Cheng Ma, Ke Fu, Lihong Gong, Yafang Zhang, Honglin Zhou, Yunxia Li	49
14	MicroRNA-214 Suppresses Ovarian Cancer by Targeting β-Catenin 2018 ·Cellular Physiology and Biochemistry ·Yang Liu, Jie Lin, (unknown), (unknown), (unknown), Honglin Zhou, Huijin Liu	17
15	siRNA Screening of a Targeted Library of DNA Repair Factors in HIV Infection Reveals a Role for Base Excision Repair in HIV Integration 2011 ·PLoS ONE ·Amy S. Espeseth, (unknown), Daria J. Hazuda, Qian Huang, Min Xu, Kristine E. Yoder, Honglin Zhou	36
16	Genome-Scale RNAi Screen for Host Factors Required for HIV Replication breakdown → 2008 ·Cell Host & Microbe ·Honglin Zhou, Min Xu, Qian Huang, Adam Gates, Xiaohua Douglas Zhang, John C. Castle, Erica Stec, Marc Ferrer, Berta Strulovici, Daria J. Hazuda, Amy S. Espeseth	615
17	Constitutive NF-κB activation by the t(11;18)(q21;q21) product in MALT lymphoma is linked to deregulated ubiquitin ligase activity 2005 ·Cancer Cell ·Honglin Zhou, Ming‐Qing Du, Vishva M. Dixit	122
18	Yersinia virulence factor YopJ acts as a deubiquitinase to inhibit NF-κB activation 2005 ·The Journal of Experimental Medicine ·Honglin Zhou, Denise M. Monack, Nobuhiko Kayagaki, Ingrid E. Wertz, (unknown), Beni B. Wolf, Vishva M. Dixit	187
19	Effects of exogenous double-stranded RNA on the basonuclin gene expression in mouse oocytes 2002 ·Science in China Series C Life Sciences ·Jun Ma, Honglin Zhou, Lei Su, Weizhi Ji	8
20	The Akt Proto-oncogene Links Ras to Pak and Cell Survival Signals 2000 ·Journal of Biological Chemistry ·Yi Tang, Honglin Zhou, Albert I. Chen, Randall N. Pittman, Jeffrey Field	198

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact